Processa Pharmaceuticals, Inc.PCSAEarnings & Financial Report
Nasdaq
PCSA Q3 2023 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-2.2M
Net Profit
$-2.1M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.08
Processa Pharmaceuticals, Inc. Q3 2023 Financial Summary
Processa Pharmaceuticals, Inc. reported revenue of $0 for Q3 2023, with a net profit of $-2.1M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-2.1M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2023 |
Processa Pharmaceuticals, Inc. Annual Revenue by Year
Processa Pharmaceuticals, Inc. annual revenue history includes year-by-year totals (for example, 2022 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2022 | $0 |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
|---|---|---|---|---|---|---|---|
| Assets | $24.3M | $21.7M | $18.6M | $8.6M | $12.4M | $10.1M | $8.1M |
| Liabilities | $1.1M | $1.6M | $1.4M | $1.1M | $2.3M | $930741 | $914847 |
| Equity | $23.2M | $20.1M | $17.2M | $7.5M | $10.1M | $9.2M | $7.2M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-1.8M | $-2.3M | $-3.0M | $-2.5M | $-2.1M | $-2.1M | $-1.8M |